Coiled Therapeutics Commences Trading on AIM After Raising £8.5 Million
Published on 3/27/2026
AI Summary
Summarized by AI from the source belowCoiled Therapeutics has officially started trading on the AIM market following a successful capital raise of £8.5 million. This funding aims to support the company's ongoing research and development initiatives. The initiation of trading marks a significant step for Coiled Therapeutics, which could impact investor perception in the biotech sector. Such fundraising events often influence stock liquidity and market participation.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
